BioAdvance

BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups. We’re an evergreen fund that continues to grow and invest. We work closely with entrepreneurs to build strong companies in the mid-Atlantic region that are focused on improving human health. Our portfolio has attracted over $4.2B in follow-on funding. Five companies have gone public, five companies have repaid our investment, and seventeen companies have been acquired bringing in over $1.84 billion in acquisition proceeds to date to investors.